Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Magli

Showing results (51-60 of 88) with videos related to

Pageof 9
Sort By:
Cell|February 25, 2010
Nfix regulates fetal-specific transcription in developing skeletal muscleGraziella Messina, Stefano Biressi, Stefania Monteverde, et al.
Critical Reviews in Oncology/Hematology|May 17, 2019
Consensus statements on ablative radiotherapy for oligometastatic prostate cancer: A position paper of Italian Association of Radiotherapy and Clinical Oncology (AIRO)Rolando M D'Angelillo, Giulio Francolini, Gianluca Ingrosso, et al.
Frontiers in Surgery|July 26, 2021
Radiation Therapy After Radical Prostatectomy: What Has Changed Over Time?Fabio Zattoni, Isabel Heidegger, Veeru Kasivisvanathan, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 2008
Development of a set of nomograms to predict acute lower gastrointestinal toxicity for prostate cancer 3D-CRTRiccardo Valdagni, Tiziana Rancati, Claudio Fiorino, et al.
Practical Radiation Oncology|November 3, 2024
Management of de Novo Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) and the Role of Radiation Therapy: A Consensus by the Italian Association of Radiotherapy and Clinical Oncology (AIRO)Andrea Lancia, Anna Rita Alitto, Giovanni Pappagallo, et al.
Journal of Clinical Medicine|December 11, 2022
Prostate Cancer Treatment-Related Toxicity: Comparison between 3D-Conformal Radiation Therapy (3D-CRT) and Volumetric Modulated Arc Therapy (VMAT) TechniquesFabrizio Tonetto, Alessandro Magli, Eugenia Moretti, et al.
Annals of Surgical Oncology|January 13, 2012
Adjuvant PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) or gemcitabine followed by chemoradiation in pancreatic cancer: a randomized phase II trialMichele Reni, Gianpaolo Balzano, Giuseppe Aprile, et al.
International Journal of Radiation Oncology, Biology, Physics|April 17, 2002
Practice patterns for prostate cancer in nine central and northern Italy radiation oncology centers: a survey including 1759 patients treated during two decades (1980-1998)Stefano Maria Magrini, Filippo Bertoni, Vittorio Vavassori, et al.
Critical Reviews in Oncology/Hematology|August 6, 2021
A Systematic Review on Intensity Modulated Radiation Therapy for Mediastinal Hodgkin's LymphomaMichela Buglione, Andrea Emanuele Guerini, Andrea Riccardo Filippi, et al.
Plos Biology|February 27, 2019
Time-dependent Pax3-mediated chromatin remodeling and cooperation with Six4 and Tead2 specify the skeletal myogenic lineage in developing mesodermAlessandro Magli, June Baik, Lauren J Mills, et al.
Pageof 9

Showing results (51-60 of 88) with videos related to

Sort By:
Pageof 9
Cell|February 25, 2010
Nfix regulates fetal-specific transcription in developing skeletal muscleGraziella Messina, Stefano Biressi, Stefania Monteverde, et al.
Critical Reviews in Oncology/Hematology|May 17, 2019
Consensus statements on ablative radiotherapy for oligometastatic prostate cancer: A position paper of Italian Association of Radiotherapy and Clinical Oncology (AIRO)Rolando M D'Angelillo, Giulio Francolini, Gianluca Ingrosso, et al.
Frontiers in Surgery|July 26, 2021
Radiation Therapy After Radical Prostatectomy: What Has Changed Over Time?Fabio Zattoni, Isabel Heidegger, Veeru Kasivisvanathan, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 2008
Development of a set of nomograms to predict acute lower gastrointestinal toxicity for prostate cancer 3D-CRTRiccardo Valdagni, Tiziana Rancati, Claudio Fiorino, et al.
Practical Radiation Oncology|November 3, 2024
Management of de Novo Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) and the Role of Radiation Therapy: A Consensus by the Italian Association of Radiotherapy and Clinical Oncology (AIRO)Andrea Lancia, Anna Rita Alitto, Giovanni Pappagallo, et al.
Journal of Clinical Medicine|December 11, 2022
Prostate Cancer Treatment-Related Toxicity: Comparison between 3D-Conformal Radiation Therapy (3D-CRT) and Volumetric Modulated Arc Therapy (VMAT) TechniquesFabrizio Tonetto, Alessandro Magli, Eugenia Moretti, et al.
Annals of Surgical Oncology|January 13, 2012
Adjuvant PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) or gemcitabine followed by chemoradiation in pancreatic cancer: a randomized phase II trialMichele Reni, Gianpaolo Balzano, Giuseppe Aprile, et al.
International Journal of Radiation Oncology, Biology, Physics|April 17, 2002
Practice patterns for prostate cancer in nine central and northern Italy radiation oncology centers: a survey including 1759 patients treated during two decades (1980-1998)Stefano Maria Magrini, Filippo Bertoni, Vittorio Vavassori, et al.
Critical Reviews in Oncology/Hematology|August 6, 2021
A Systematic Review on Intensity Modulated Radiation Therapy for Mediastinal Hodgkin's LymphomaMichela Buglione, Andrea Emanuele Guerini, Andrea Riccardo Filippi, et al.
Plos Biology|February 27, 2019
Time-dependent Pax3-mediated chromatin remodeling and cooperation with Six4 and Tead2 specify the skeletal myogenic lineage in developing mesodermAlessandro Magli, June Baik, Lauren J Mills, et al.
Pageof 9